NCT05011708

I-DROP MGD Symptomatic Relief and Tear Film Stability

Examining Symptomatic Relief and Kinetic Stability of I-DROP MGD Eye Drops (LIME)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: I-MED Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of the study is to compare the difference in tear film stability and symptomatic relief between I-DROP MGD and another commercially available drop in the Canadian market.

Detailed description

The purpose of this study is to: * Compare tear film measurements for two hours after putting one drop of I-DROP MGD eye drops into one eye and one drop of Thealoz Duo eye drops in the other eye. * Investigate the relief of dry eye symptoms with I-DROP MGD eye drops after 7 days of use.

Conditions

• Dry Eye

Interventions

Type	Name	Description
DEVICE	I-DROP MGD	I-DROP MGD are eye drop produced by I-MED PHARMA for the management of moderate to severe Dry Eye Disease.
DEVICE	Thealoz Duo	I-DROP MGD are eye drop produced by Laboratoires Thea for the management of Dry Eye Disease.

Timeline

• Start date: 2021-08-23
• Primary completion: 2021-12-15
• Completion: 2022-01-12
• First posted: 2021-08-18
• Last updated: 2022-03-29

Locations

2 sites across 1 country: Canada